Lazareno S, Marriott D B, Nahorski S R
Brain Res. 1985 Dec 30;361(1-2):91-8. doi: 10.1016/0006-8993(85)91278-8.
Cyclic AMP was measured in both striatal slices and in the incubation medium after exposure to dopamine and dopamine antagonist. Dopamine increased cyclic AMP in both tissue and medium. The effect of dopamine was enhanced by sulpiride and domperidone, and to a lesser extent by haloperidol, but alpha-fluphenthixol had only an inhibitory effect. The enhancement by sulpiride was stereoselective and totally suppressed by the D1 antagonist SCH 23390. Cyclic AMP in the medium provided the more sensitive measure of drug effect and increased linearly for up to 20 min., whereas the nucleotide in tissue remained stable or declined after 10 min. It is concluded that: the increase in dopamine-stimulated cyclic AMP efflux caused by D2 antagonists reflects increased intracellular cyclic AMP accumulation rather than an effect on the efflux mechanism; dopamine enhances cyclic AMP accumulation via a D1 receptor, and simultaneously inhibits it through a D2 receptor; and changes in D1 receptor-stimulated cyclic AMP formation in striatum may not be related to the clinical actions of neuroleptics. It remains possible that D2 receptor-mediated inhibition of cyclic AMP accumulation stimulated by a different agonist system may underlie some of the therapeutic actions of dopamine agonists and antagonists.
在暴露于多巴胺和多巴胺拮抗剂后,对纹状体切片和孵育培养基中的环磷酸腺苷(cAMP)进行了测量。多巴胺使组织和培养基中的cAMP均增加。舒必利和多潘立酮增强了多巴胺的作用,氟哌啶醇的增强作用较小,但α-氟奋乃静仅具有抑制作用。舒必利的增强作用具有立体选择性,并被D1拮抗剂SCH 23390完全抑制。培养基中的cAMP提供了更灵敏的药物效应测量指标,在长达20分钟内呈线性增加,而组织中的核苷酸在10分钟后保持稳定或下降。得出以下结论:D2拮抗剂引起的多巴胺刺激的cAMP流出增加反映了细胞内环磷酸腺苷积累增加,而不是对流出机制的影响;多巴胺通过D1受体增强环磷酸腺苷积累,同时通过D2受体抑制它;纹状体中D1受体刺激的环磷酸腺苷形成的变化可能与抗精神病药物的临床作用无关。多巴胺激动剂和拮抗剂的一些治疗作用可能仍然是由D2受体介导的对不同激动剂系统刺激的环磷酸腺苷积累的抑制作用所致。